Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Chronic Progressive

Explore clinical trials studying Multiple Sclerosis, Chronic Progressive. Study availability and eligibility vary by location and protocol.

186 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Chronic Progressive trial results

Completed

Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis

NCT02228213

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • The Wesley-St. Andrew's Research Institute Brisbane, Queensland, Australia
  • PARC Clinical Research Adelaide, South Australia, Australia
  • Nucleus Network - Centre for Clinical Studies Melbourne, Victoria, Australia
  • Western Australian Neuroscience Research Institute Perth, Western Australia, Australia
View Trial Details
Completed

Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis

NCT01684761

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Atrophy, +12 more
Locations
  • HOPE Research Institute Phoenix, Arizona, United States
  • Northwest NeuroSpecialists, LLC Tucson, Arizona, United States
  • Alta Bates Summit Medical Center, The Research and Education Development Institute Berkeley, California, United States
  • Neurology Associates, P.A. Maitland, Florida, United States
View all 36 locations
View Trial Details

Related conditions